U.S. Banks Stock News

10x Genomics, Inc. ( NASDAQ:TXG ) shareholders would be excited to see that the share price has had a great month...

The ChargePoint Holdings, Inc. ( NYSE:CHPT ) share price has fared very poorly over the last month, falling by a...

CompoSecure reported its third quarter 2025 earnings, revealing a net loss of US$174.7 million alongside a substantial drop in sales for both the quarter and the nine months ended September 30, 2025, compared to a year earlier; the company also announced two board additions and a company executive's participation at the General Counsel Conference East. The scale of operational challenges is exceptional, with losses and sales declines far exceeding the prior year's results, highlighting a...

Innovative Aerosystems (ISSC) has added Richard Silfen to its board as an independent director. This appointment increases the board’s size and brings fresh M&A and capital markets experience at a strategic moment for the company. See our latest analysis for Innovative Aerosystems. Shares of Innovative Aerosystems have had a rollercoaster year, with short-term volatility recently intensifying. Just last month, the share price fell 27.7%, though over the past 12 months shareholders have still...

Earlier this month, Ingredion Incorporated announced a new share repurchase program authorizing the buyback of up to 8 million shares through December 2028, and reported its third quarter 2025 results, with sales of US$1.82 billion and net income of US$171 million. The company also updated its full-year 2025 guidance with expected flat to low single-digit declines in net sales and reported EPS forecasted between US$11.11 and US$11.31, signaling continued focus on operational discipline amid...

Ever wondered if Quanta Services is fairly valued these days? With so many investors eyeing the stock's long climb, now is a great time to dig deeper into what its price really means. The stock recently closed at $426.93 and while it dipped 3.6% over the last week, it is still up an impressive 35.3% year-to-date and 32.0% over the last year, reflecting strong long-term gains. Some of this price action has been punctuated by industry headlines highlighting Quanta's expanding role in energy...

Dianthus Therapeutics recently announced positive topline results from its Phase 2 MaGic study of claseprubart for myasthenia gravis, prompting plans to advance to a Phase 3 trial in 2026. This development has positioned the company as a prominent contender in the evolving field of autoimmune disease therapies targeting unmet medical needs. We'll explore how the successful Phase 2 results for claseprubart reinforce Dianthus Therapeutics' investment narrative and pipeline momentum. Rare earth...

As the U.S. stock market navigates a mixed landscape with tech shares rebounding and the Dow Jones Industrial Average experiencing declines, investors are closely watching for opportunities amid fluctuating indices. In this environment, identifying undervalued stocks becomes crucial, as they may present potential value plays despite broader market volatility and economic uncertainties.

The U.S. stock market has been experiencing mixed movements, with the Dow Jones Industrial Average declining for a second consecutive day while technology shares show signs of recovery. Amid these fluctuations, investors are often on the lookout for stocks that offer potential growth opportunities at lower price points. Penny stocks, though an older term, continue to represent a niche investment area where smaller or newer companies can shine. When these stocks boast strong financial health...

As the U.S. stock market experiences mixed movements with technology shares rebounding and the Dow Jones Industrial Average declining for a second consecutive day, investors are closely watching economic indicators following a prolonged government shutdown. In such uncertain times, dividend stocks can provide a measure of stability and income, making them an attractive option for those looking to bolster their portfolios amidst fluctuating market conditions.

Wondering if Day One Biopharmaceuticals is a smart buy right now? You are not alone, as many investors are starting to ask whether this stock's current price really reflects its future potential. Over the past month, Day One's stock has jumped 25.5%, even though it is still down 30.4% year-to-date and 38.2% in the last year. This has created a rollercoaster ride for shareholders and watchers alike. Recent headlines have focused on key clinical trial updates and new regulatory developments,...

Kosmos Energy (NYSE:KOS) just published its third quarter earnings results, reported forward-looking production guidance for 2025, and outlined a series of steps to reduce debt obligations. These recent developments may shift investor expectations. See our latest analysis for Kosmos Energy. Kosmos Energy’s string of operational updates, including a modest lift in quarterly production, fresh guidance for 2025, and proactive debt repayment plans, has arrived against a backdrop of continued...

Adams Diversified Equity Fund, Inc. has declared a distribution of $0.46 per share, payable on December 23, 2025 to shareholders of record as of November 21, 2025, with the option for payment in shares or cash. This announcement extends the Fund's remarkable track record, marking its 61st consecutive year of capital gains payouts and 90th year of dividends. We'll explore how the Fund's sustained commitment to regular distributions shapes its investment narrative and appeals to income-focused...

Global Partners LP reported its third-quarter 2025 earnings, posting sales of US$4.69 billion and net income of US$24.23 million, both changes from the previous year, along with a long-lived asset impairment of US$20,000. Despite year-over-year declines in net income and earnings per share, the company maintained its dividend and cited solid performance in its Wholesale segment while highlighting ongoing challenges in gasoline distribution and station operations. We'll explore how the weaker...

Ever wondered if Illumina could be a hidden gem, potentially undervalued and offering an opportunity that others might be missing? Despite a recent 29.0% surge over the past month, Illumina's stock is still down -8.4% year-to-date and trails its levels from one and five years ago. News around the company has been lively, with investors reacting to developments in Illumina's strategy and leadership. Recent headlines have spotlighted board changes and ongoing discussions about its future...

Key Insights BJ's Restaurants' estimated fair value is US$32.04 based on 2 Stage Free Cash Flow to Equity With US$37.20...

NextNRG Inc. announced it would report its third quarter 2025 earnings on November 14, 2025, giving investors a key update on operational progress and financial performance. This scheduled release comes as market participants seek more insight into the company's expanding integrated energy offerings and increasing project pipeline. With the Q3 results now released, we'll examine how expectations for improved operational metrics and business scale could influence NextNRG's investment...

The market was pleased with the recent earnings report from Madison Square Garden Entertainment Corp. ( NYSE:MSGE...

Ball Corporation ( NYSE:BALL ) just reported healthy earnings but the stock price didn't move much. We think that...

The board of Myers Industries, Inc. ( NYSE:MYE ) has announced that it will pay a dividend of $0.135 per share on the...

Readers hoping to buy Rockwell Automation, Inc. ( NYSE:ROK ) for its dividend will need to make their move shortly, as...

It's been a pretty great week for Organon & Co. ( NYSE:OGN ) shareholders, with its shares surging 14% to US$7.62 in...

Despite an already strong run, Viavi Solutions Inc. ( NASDAQ:VIAV ) shares have been powering on, with a gain of 32% in...

Viasat, Inc. ( NASDAQ:VSAT ) came out with its second-quarter results last week, and we wanted to see how the business...